Ryota Sumitomo
Overview
Explore the profile of Ryota Sumitomo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
221
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
M2-like tumor-associated macrophages may promote tumor progression in malignant pleural mesothelioma
Fukui T, Sumitomo R, Menju T, Kobayashi M, Sakai H, Date H
Transl Oncol
. 2025 Feb;
54:102324.
PMID: 39983469
Introduction: Malignant pleural mesothelioma (MPM) is an aggressive malignancy with an unfavorable prognosis. Asbestos-activated macrophages may contribute to both oncogenesis and progression of MPM. This study aimed to clarify the...
2.
Chiba N, Menju T, Shimazu Y, Toyazaki T, Sumitomo R, Miyamoto H, et al.
Cancer Manag Res
. 2025 Jan;
17:91-102.
PMID: 39866192
Background: Signaling pathways centered on the G-protein ADP-ribosylation factor 6 (Arf6) and its downstream effector ArfGAP with the SH3 Domain, Ankyrin Repeat and PH Domain 1 (AMAP1) drive cancer invasion,...
3.
Takahashi M, Aoyama A, Hamaji M, Sozu T, Kobayashi M, Nakagawa T, et al.
Surg Today
. 2025 Jan;
PMID: 39815110
Purpose: To validate the clinical impacts of the prognostic nutritional index (PNI), an immune-nutritional blood marker, in patients with resectable non-small cell lung cancer (NSCLC) using multicenter cohort data. Methods:...
4.
Nakajima D, Sakanoue I, Kayawake H, Sumitomo R, Nishikawa S, Tanaka S, et al.
Eur J Cardiothorac Surg
. 2024 Nov;
66(6).
PMID: 39607787
Objectives: This study was designed to examine the outcomes of adult living-donor lobar lung transplants (LDLLTs) using small-for-size grafts. Methods: A calculated graft forced vital capacity of <50% of the...
5.
Sumitomo R, Menju T, Shimazu Y, Toyazaki T, Chiba N, Miyamoto H, et al.
Cancer Sci
. 2023 Oct;
114(12):4521-4534.
PMID: 37806311
Epithelial-mesenchymal transition (EMT) promotes primary tumor progression toward a metastatic state. The role of tumor-associated macrophages (TAMs) in inducing EMT in lung squamous cell carcinoma (LUSC) remains unclear. We aimed...
6.
Sumitomo R, Huang C, Ando H, Ishida T, Cho H, Date H
Oncol Rep
. 2022 Sep;
48(5).
PMID: 36102318
Tumor‑associated macrophages (TAMs), particularly M2 macrophages, promote tumor progression, while genes encode a family of multi‑functional glycoproteins that serve an important role in tumorigenesis. Immunohistochemical studies were performed to evaluate...
7.
Miyata R, Hamaji M, Kawaguchi A, Shimazu Y, Ikeda M, Ishikawa M, et al.
Eur J Cardiothorac Surg
. 2022 Aug;
62(5).
PMID: 35997576
Objectives: The aim of this study was to analyse the long-term survival outcomes and prognostic factors of patients receiving epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) as first-line treatment...
8.
Miyata R, Hamaji M, Nakakura A, Morita S, Shimazu Y, Ishikawa M, et al.
Surg Today
. 2022 Jul;
53(1):135-144.
PMID: 35780275
Purpose: The effect of postoperative tegafur-uracil on overall survival (OS) after resection of stage I adenocarcinoma has been shown in clinical trials. The purpose of this study was to investigate...
9.
Sumitomo R, Huang C, Fujita M, Cho H, Date H
Oncol Rep
. 2022 Feb;
47(4).
PMID: 35169863
To improve the treatment strategy of immune‑checkpoint inhibitors for non‑small cell lung cancer (NSCLC), a comprehensive analysis of programmed death‑ligand (PD‑L)1 and PD‑L2 expression is clinically important. The expression of...
10.
Hamaji M, Omasa M, Nakanishi T, Nakakura A, Morita S, Miyamoto E, et al.
Interact Cardiovasc Thorac Surg
. 2021 Jun;
33(2):242-249.
PMID: 34151358
Objectives: Although lymph node (LN) metastases are not uncommon in thymic carcinomas, preoperative LN evaluation, intraoperative lymph node dissection (LND) and postoperative outcomes remain unknown. The aim of this study...